Objective: We evaluate the performance of three MRI methods to determine non-invasively tumor size, as overall survival (OS) and Progression Free Survival (PFS) predictors, in a cohort of wild type, IDH negative, glioblastoma patients. Investigated protocols included bidimensional (2D) diameter measurements, and three-dimensional (3D) estimations by the ellipsoid or semi-automatic segmentation methods.
Authors: Alexis Junnior Palpan Flores, Catalina Vivancos Sanchez, Jose María Roda , Sebastian Cerdan, Andres Javier Barrios, Cristina Utrilla, Aranzazu Royo, Maria Luisa Gandía-González
Dear Jose M. Roda,
Oncology Production Office has sent you a message. Please click 'Reply' to send a direct response
Congratulations on the publication of your article: Assessment of Pre-operative Measurements of Tumor Size by MRI Methods as Survival Predictors in Wild Type IDH Glioblastoma, by Alexis Junnior Palpan Flores, Catalina Vivancos Sanchez, Jose María Roda, Sebastian Cerdan, Andres Javier Barrios, Cristina Utrilla, Aranzazu Royo, Maria Luisa Gandía-González, published in Frontiers in Oncology, section Neuro-Oncology and Neurosurgical Oncology.
The use of transcranial motor-evoked potentials, somatosensory-evoked potentials and free-run electromyography for proper placement of paddle leads in chronic pain
Authors: José F. Paz, María del Mar Santiago Sanz, María Victoria Paz-Domingo, María Luisa Gandía-González, Susana Santiago-Pérez, Jose María Roda Frade
As an alternative to those patients who cannot be performed an awake spinal cord stimulation (SCS) or had been percutaneously implanted with poor pain relief outcomes, neurophysiological monitoring through transcranial motor evoked potentials (MEPs), somatosensory-evoked potentials (SSEPs) and free-run electromyography (EMG) under general anesthesia allows the correct placement of surgical leads and provide objective responses.
We read with interest the report by Zoia, and we would like to widen the picture by sharing our experience in Madrid’s COVID-19 reference center, one of the hardest hit areas in Europe. As neurosurgeons, we never would have imagined being in the eye of the storm. We hope our humble experience can be helpful to colleagues in other countries.
Authors: Maria L. Gandía-González, Miguel Sáez-Alegre, José M. Roda
On 27 April 2020, Spain represented the hardest hitEuropean country by the COVID-19 pandemic with 219,764cases and 48.2 deaths per 100,000 inhabitants. Madrid becamethe epicenter of the outbreak, with 59,126 cases diagnosed,and a death toll of 7,922 hospitalized victims.